0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > PD-1

PD-1

Brief Information

Name:Programmed cell death protein 1
Target Synonym:Programmed cell death protein 1,CD279,hPD-1,PDCD1,Programmed Cell Death 1,Systemic Lupus Erythematosus Susceptibility 2,Protein PD-1,PD1,Programmed Cell Death 1 Protein,CD279 Antigen,HPD-L,HSLE1,SLEB2,PD-1,Programmed Cell Death 1 Receptor
Number of Launched Drugs:17
Number of Drugs in Clinical Trials:141
Lastest Research Phase:Approved

Antibody Licensing

Project Name Project Stage Molecule Type Host Species Therapeutic Area Indications
PD-1 VHH mAb - 01 PCC Solid Tumor Solid tumor

Licensing

Project Name Modality Therapeutic Area Indications Stage Right Available
SIRPα×PD-1 bsAb Bispecific antibody Oncology/Cancer Advanced solid tumor Preclinical Global
PD-1×TIGIT BsAb for Advanced solid tumor Bispecific antibody Oncology/Cancer Cancer Preclinical Global
SN-38 Polymeric Nanoparticle (new formulation) Small molecule Oncology/Cancer Solid tumor,Lung cancer Phase II Global

Product ListCompare or Buy

Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
CHEK-ATP143 Human HEK293/Human PD-1 Stable Cell Line
PD1-M82E3 Mouse Mouse PD-1 / PDCD1 Protein, His,Avitag™ (MALS verified)
PD1-M82E3-structure
PD1-M82E3-sds
PD1-M5257 Mouse Mouse PD-1 / PDCD1 Protein, Mouse IgG2a Fc Tag (MALS verified)
PD1-M5257-structure
PD1-M5257-sds
PD1-C82F7 Cynomolgus Biotinylated Cynomolgus PD-1 / PDCD1 Protein, Fc,Avitag™ (MALS verified)
PD1-C82F7-structure
PD1-C82F7-sds
HGS-S238 Mouse Recombinant Monoclonal Anti-PD-1 Antibody, Mouse (2F3)
PD1-H5286 Human Human PD-1 / PDCD1 Protein, Twin-Strep Tag (MALS verified)
PD1-H5286-structure
PD1-H5286-sds
EP-154 Human PD-1 : PD-L2 [Biotinylated] Inhibitor Screening ELISA Kit
SCJUR-STF064 Human Human PD-1 (Luc) Jurkat Reporter Cell Development Service
PD1-C52H5 Cynomolgus Cynomolgus PD-1 / PDCD1 Protein, His Tag (MALS verified)
PD1-C52H5-structure
PD1-C52H5-sds
RAB-P002 Human Human Anti-PD-1 Antibody IgG Titer Serologic ELISA Assay Kit
PD1-C52E5 Canine Biotinylated Canine PD-1 / PDCD1 Protein, His,Avitag™
PD1-C52E5-structure
PD1-C52E5-sds
EP-120 Human PD-1 [Biotinylated] : PD-L2 Inhibitor Screening ELISA Kit
EP-130 Human PD-1 : PD-L1 [Biotinylated] Inhibitor Screening ELISA Kit
PD1-H5256 Human Human PD-1 / PDCD1 Protein, Fc,His Tag
PD1-H5256-structure
PD1-H5256-sds
PD1-H52H2 Human Human PD-1 Protein, His Tag (Nanoparticle)
PD1-H52H2-sds
PD1-C52H9 Canine Canine PD-1 / PDCD1 Protein, His Tag (MALS verified)
PD1-C52H9-structure
PD1-C52H9-sds
PD1-H82A4 Human Biotinylated Human PD-1 / PDCD1 Protein, Mouse IgG2a Fc,Avitag™ (MALS verified)
PD1-H82A4-structure
PD1-H82A4-sds
PD1-R52H3 Rhesus macaque Rhesus macaque PD-1 / PDCD1 Protein, His Tag (MALS verified)
PD1-R52H3-structure
PD1-R52H3-sds
PD1-H52H6 Human Human PD-1 / PDCD1 Full Length Protein, His Tag
PD1-H52H6-structure
PD1-H52H6-sds
PD1-H82F4 Human Biotinylated Human PD-1 / PDCD1 Protein, Fc,Avitag™,His Tag (MALS verified)
PD1-H82F4-structure
PD1-H82F4-sds
PD1-C82E6 Cynomolgus Biotinylated Cynomolgus PD-1 / PDCD1 Protein, His,Avitag™
PD1-C82E6-structure
PD1-C82E6-sds
PD1-HP2F2 Human PE-Labeled Human PD-1 / PDCD1 Protein, Fc,His Tag (recommended for neutralizing assay)
PD1-HP2F2-structure
PD1-H5255 Human Human PD-1 / PDCD1 Protein, Mouse IgG2a Fc Tag (HPLC-verified)
PD1-H5255-structure
PD1-H5255-sds
PD1-H5255-hplc
PD1-H522a Human Human PD-1 / PDCD1 Protein, His Tag, low endotoxin (MALS verified)
PD1-H522a-structure
PD1-H522a-sds
EPC-V1 Monkey ELISA Assay Kit for Anti-PD-1 h-mAb in Monkey Serum
EPM-V1 Mouse ELISA Assay Kit for Anti-PD-1 h-mAb in Mouse Serum
PD1-H5259 Human Human PD-1 / PDCD1 Protein, Llama IgG2b Fc Tag, low endotoxin
PD1-H5259-structure
PD1-H5259-sds
EPH-V1 Human ELISA Assay Kit for Anti-PD-1 h-mAb in Human Serum
PD1-H82F1 Human Biotinylated Human PD-1 / PDCD1 Protein, Fc,Avitag™ (MALS verified)
PD1-H82F1-structure
PD1-H82F1-sds
PD1-RB5251 Rabbit Rabbit PD-1 / PDCD1 Protein, Fc Tag
PD1-RB5251-structure
PD1-RB5251-sds
PD1-R52H2 Rat Rat PD-1 / PDCD1 Protein, His Tag
PD1-R52H2-structure
PD1-R52H2-sds
PD1-H82E4 Human Biotinylated Human PD-1 / PDCD1 Protein, Avitag™,His Tag (recommended for biopanning) (MALS verified)
PD1-H82E4-structure
PD1-H82E4-sds
PD1-R52H0 Rabbit Rabbit PD-1 / PDCD1 Protein, His Tag (MALS verified)
PD1-R52H0-structure
PD1-R52H0-sds
PD1-M82F4 Mouse Biotinylated Mouse PD-1 / PDCD1 Protein, Fc,Avitag™ (MALS Verified)
PD1-M82F4-structure
PD1-M82F4-sds
PD1-R5253 Rat Rat PD-1 / PDCD1 Protein, Fc Tag
PD1-R5253-structure
PD1-R5253-sds
PD1-M5259 Mouse Mouse PD-1 / PDCD1 Protein, Fc Tag
PD1-M5259-structure
PD1-M5259-sds
PD1-H5284 Human Human PD-1 / PDCD1 Protein, Twin-Strep Tag (MALS verified)
PD1-H5284-structure
PD1-H5284-sds
PD1-M5228 Mouse Mouse PD-1 / PDCD1 Protein, His Tag
PD1-M5228-structure
PD1-M5228-sds
PD1-C5254 Cynomolgus Cynomolgus PD-1 / PDCD1 Protein, Fc Tag (MALS verified)
PD1-C5254-structure
PD1-C5254-sds
PD1-H5257 Human Human PD-1 / PDCD1 Protein, Fc Tag, low endotoxin (MALS Verified)
PD1-H5257-structure
PD1-H5257-sds
PD1-H5221 Human Human PD-1 / PDCD1 Protein, His Tag (MALS Verified)
PD1-H5221-structure
PD1-H5221-sds
ACRO Quality

Part of Bioactivity data

CHEK-ATP143-Cell-based assay
 PD-1 FACS

Fig. FACS analysis of PD-1 on HEK293/Human PD-1 Stable Cell Line.
FACS assay shows that Human PD-L1 Protein, Mouse IgG1 Fc Tag can bind to HEK293/Human PD-1 Stable Cell Line. HEK293/Human PD-1 Stable Cell Line was red line, negative control HEK293 cells was grey line(QC tested).

SCJUR-STF064-Cell-based assay
 PD-1 FACS

Expression analysis of human PD-1 on Human PD-1 (Luc) Jurkat Reporter Cell by FACS.
Human PD-1 (Luc) Jurkat Reporter Cell or negative control cell were stained with FITC-labeled anti-human PD1 antibody.

PD1-R52H0-SPR
Human_FcRn_Heterodimer_Protein_SPR

Rabbit PD-L1, His Tag (Cat. No. PDL-R52H6) immobilized on CM5 Chip can bind Rabbit PD-1, His Tag (Cat. No. PD1-R52H0) with an affinity constant of 3.87 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

PD1-M5259-SPR
 PD-1 SPR

Captured Mouse PD-1, Fc Tag (Cat. No. PD1-M5259) on Protein A Chip can bind Mouse PD-L1, His Tag (Cat. No. PD1-M5220) with an affinity constant of 2.16 μM as determined in SPR assay (Biacore T200) (Routinely tested).

Customer Reviews

Synonym Name

PDCD1,PD1,CD279,SLEB2

Background

How a therapeutic antibody is metabolized in the body is pertinently relevant to its efficacy. Therefore, pharmacokinetics study is an important part of the drug development. PD-1 is probably the most targeted molecule in today’s pharmaceutical industry, thanking to the clinical success of Keytruda® and Opdivo®. Many investigational anti-PD-1 mAbs are being developed. There is a growing need for a standard assay that can be used to facilitate the study of their pharmacokinetics.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Zimberelimab AB-122; GLS-010; WBP-3055 Approved Wuxi Biologics (Shanghai) Co Ltd, Harbin Gloria Pharmaceuticals Co Ltd 誉妥, YUTUO Mainland China Hodgkin Disease Guangzhou Gloria Biosciences Co Ltd 2021-08-25 Prostatic Neoplasms, Castration-Resistant; Adenocarcinoma; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal adenocarcinoma; Endometrial Neoplasms; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Lymphoma, Non-Hodgkin; Carcinoma, Squamous Cell; Colorectal Neoplasms; Breast Neoplasms; Multiple Myeloma; Urinary Bladder Neoplasms; Solid tumours; Neoplasms; Triple Negative Breast Neoplasms; Hodgkin Disease; Glioblastoma; Pancreatic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Stomach Neoplasms; Liver Neoplasms; Biliary Tract Neoplasms; Ovarian Neoplasms Details
Penpulimab AK-105 Approved Zhongshan Akeso Biopharma Co Ltd 安尼可, ANNIKO Mainland China Hodgkin Disease Zhengda Tianqing Kangfang (Shanghai) Biomedical Technology Co Ltd 2021-08-03 Neuroendocrine Tumors; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Lung Neoplasms; Carcinoma, Squamous Cell; Lymphoma, Non-Hodgkin; Urologic Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Microsatellite instability-high cancer; Neoplasms; Small Cell Lung Carcinoma; Hodgkin Disease; Esophageal Neoplasms; Thoracic Neoplasms; Head and Neck Neoplasms; Liver Neoplasms Details
Toripalimab TAB-001; JS-001; SO-001; JS-001sc; CHS-007 Approved Shanghai Junshi Biosciences Co Ltd, Suzhou Union Biopharm Biosciences Co Ltd 拓益, LOQTORZI Mainland China Melanoma Shanghai Junshi Biosciences Co Ltd 2018-12-17 Lymphoma; Rejection of organ transplantation; Urinary Bladder Neoplasms; Sarcoma; Breast Neoplasms; Nasopharyngeal Carcinoma; Cholangiocarcinoma; Colorectal Neoplasms; Urologic Neoplasms; Neuroendocrine Tumors; Epstein-Barr Virus Infections; Esophageal Squamous Cell Carcinoma; Laryngeal Neoplasms; Lung Neoplasms; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Stomach Neoplasms; Solid tumours; Colorectal Neoplasms, Hereditary Nonpolyposis; Head and Neck Neoplasms; Kidney Neoplasms; Carcinoma, Renal Cell; Anus Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Biliary Tract Neoplasms; Pain; Triple Negative Breast Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Carcinoma, Transitional Cell; Nasopharyngeal Neoplasms; Nasopharyngeal Diseases; Hypopharyngeal Neoplasms Details
Prolgolimab BCD-100 Approved Biocad Forteca Russian Federation Melanoma Biocad 2020-04-01 Carcinoma, Renal Cell; Lung Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms Details
Cadonilimab AK-104 Approved Zhongshan Akeso Biopharma Co Ltd 开坦尼 Mainland China Uterine Cervical Neoplasms Kangfang Pharmaceutical Co Ltd 2022-06-29 Microsatellite Instability; Adenocarcinoma; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Esophageal Squamous Cell Carcinoma; Colorectal Neoplasms; DNA Repair-Deficiency Disorders; Urologic Neoplasms; Vulvar Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Microsatellite instability-high cancer; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Triple Negative Breast Neoplasms; Vaginal Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Carcinoma; Lymphoma, T-Cell, Peripheral Details
Cemiplimab REGN-2810; SAR-439684 Approved Regeneron Pharmaceuticals Inc Libtayo United States Carcinoma, Squamous Cell Regeneron Pharmaceuticals Inc 2018-09-28 Mouth Neoplasms; Sarcoma; Peritoneal Neoplasms; Diffuse Intrinsic Pontine Glioma; Carcinoma, Squamous Cell; Lung Neoplasms; Brain metastases; Fallopian Tube Neoplasms; Carcinoma, Brown-Pearce; Prostatic Neoplasms; Glioma; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Uterine Cervical Neoplasms; Mycosis Fungoides; Melanoma; Carcinoma, Hepatocellular; Skin Neoplasms; Solid tumours; HIV Infections; Carcinoma, Bronchogenic; Carcinoma, Basal Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Merkel Cell; Hemangiosarcoma; Carcinoma, Renal Cell; Ovarian Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Hodgkin Disease; Colonic Neoplasms; Papillomavirus Infections; Central Nervous System Neoplasms; Multiple Myeloma; Hepatitis B Details
Nivolumab MDX-1106; BMS-936558; BMS-936558-01; ono-0123; ONO-4538 Approved Ono Pharmaceutical Co Ltd, Bristol-Myers Squibb Company 欧狄沃, Opdivo Japan Melanoma Ono Pharmaceutical Co Ltd 2014-07-04 Liver Neoplasms; Hematologic Neoplasms; Solid tumours; Tobacco Smoking; Drug-Related Side Effects and Adverse Reactions; Biliary Tract Neoplasms; Acquired Immunodeficiency Syndrome; Head and Neck Neoplasms; Ovarian Neoplasms; Bone Marrow Neoplasms; Colorectal Neoplasms, Hereditary Nonpolyposis; Lymphoma, T-Cell, Peripheral; Leiomyosarcoma; Kidney Neoplasms; Ependymoma; Medulloblastoma; Leukemia, Myelogenous, Chronic; Hematopoietic stem cell transplantation (HSCT); HIV Infections; Esophageal Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Mismatch Repair Deficient Cancer; Anus Neoplasms; Leukoplakia, Oral; Leukemia, Lymphoid; Carcinoma, Merkel Cell; Polycythemia Vera; Carcinoma; Giant Cell Arteritis; Thoracic Neoplasms; Inflammatory Bowel Diseases; Dermatomyositis; Neoplasms; Nasopharyngeal Neoplasms; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Hodgkin Disease; Autoimmune Diseases; Myelodysplastic Syndromes; Pancreatic Neoplasms; Adrenal Cortex Neopla Details
Nivolumab/Relatlimab BMS-986213; BMS-936558/BMS-986016 Approved Bristol-Myers Squibb Company OPDUALAG United States Melanoma Bristol-Myers Squibb Company 2022-03-18 Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Merkel Cell; Colorectal Neoplasms; Melanoma Details
Sintilimab IBI-308 Approved Innovent Biologics(Suzhou) Co Ltd Tyvyt, 达伯舒 Mainland China Hodgkin Disease Innovent Biologics(Suzhou) Co Ltd 2018-12-24 Lung Diseases; Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Lymphoma, Non-Hodgkin; Neoplasms, Unknown Primary; Lung Neoplasms; Esophageal Squamous Cell Carcinoma; Colorectal Neoplasms; Sarcoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell, Peripheral; Nasopharyngeal Neoplasms; Hodgkin Disease; Respiratory Tract Diseases; Neoplasms; Hemangiosarcoma; Thoracic Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Liver Neoplasms; Solid tumours Details
Serplulimab HLX-10 Approved Shanghai Henlius Biotech Inc 汉斯状, Zerpidio, Han Si Zhuang, HANSIZHUANG Mainland China Microsatellite instability-high cancer Shanghai Henlius Biopharmaceuticals Co Ltd 2022-03-22 Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Colorectal Neoplasms; Microsatellite Instability; Microsatellite instability-high cancer; Neoplasms; Solid tumours; Small Cell Lung Carcinoma; Hepatitis B, Chronic; Carcinoma; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Liver Neoplasms; Head and Neck Neoplasms Details
Tislelizumab BGB-A317; VDT-482 Approved Beigene Ltd 百泽安, Tevimbra, TEVIMBRA Mainland China Hodgkin Disease Beigene (Shanghai) Biotechnology Co Ltd 2019-12-26 Lung Neoplasms; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Mantle-Cell; Cholangiocarcinoma; Lymphoma, Follicular; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Lymphoma, T-Cell, Cutaneous; Lymphoma; Carcinoma, Squamous Cell; Nasopharyngeal Carcinoma; Metastatic breast cancer; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Mismatch Repair Deficient Cancer; Lymphoma, T-Cell, Peripheral; Liver Neoplasms; Lymphoma, B-Cell, Marginal Zone; Leukemia; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Solid tumours; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Hodgkin Disease; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Microsatellite instability-high cancer; Urinary Bladder Neoplasms; Digestive System Neoplasms Details
Retifanlimab MGA-012; INCMGA-0012; INCMGA-00012 Approved Macrogenics Inc ZYNYZ United States Carcinoma, Merkel Cell Incyte Corp 2023-03-22 Carcinoma, Squamous Cell; Neuroendocrine Tumors; Liposarcoma; Breast Neoplasms; Lymphoma, Follicular; Sarcoma; Astrocytoma; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Glioma; Digestive System Neoplasms; Endometrial Neoplasms; Esophageal adenocarcinoma; Penile Neoplasms; Neoplasm Metastasis; Carcinoma, Endometrioid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms; Melanoma; Neoplasms; Solid tumours; Ovarian Neoplasms; Lymphoma, B-Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Anus Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Merkel Cell; Head and Neck Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Malignant Carcinoid Syndrome; Lymphoma, Large B-Cell, Diffuse; Glioblastoma; Prostatic Neoplasms, Castration-Resistant; Oligodendroglioma; Urinary Bladder Neoplasms Details
Dostarlimab WBP-285; TSR-042; ANB-011; GSK-4057190 Approved Anaptysbio Inc JEMPERLI, Jemperli EU Endometrial Neoplasms Glaxosmithkline (Ireland) Ltd 2021-04-21 Sarcoma, Clear Cell; Neoplasms, Second Primary; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Neuroendocrine; Fallopian Tube Neoplasms; Lung Neoplasms; Endometrial Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Breast Neoplasms; Solid tumours; Gestational Trophoblastic Disease; Mesothelioma; Small Cell Lung Carcinoma; Colonic Neoplasms; Pancreatic Neoplasms; Neoplasms; Rectal Neoplasms; Mismatch Repair Deficient Cancer; Head and Neck Neoplasms; Ovarian Neoplasms Details
Socazolimab STIA-1014; ZKAB-001; STI-1014; ZKAB001; STI-A1014 Approved Zhaoke (Guangzhou) Oncology Pharmaceutical Ltd Mainland China Uterine Cervical Neoplasms Zhaoke (Guangzhou) Oncology Pharmaceutical Ltd 2023-12-19 Biliary Tract Neoplasms; Esophageal Neoplasms; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Osteosarcoma; Bile Duct Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma; Uterine Cervical Neoplasms Details
Pucotenlimab AK-103; HX-008 Approved Taizhou Hanzhong Biomedical Co Ltd, Hanx Biopharmaceutical Co Ltd, Zhongshan Akeso Biopharma Co Ltd, Lepu Biotech Co Ltd 普佑恒 Mainland China Microsatellite instability-high cancer; Mismatch Repair Deficient Cancer Lepu Biotech Co Ltd 2022-07-19 Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Mismatch Repair Deficient Cancer; Thyroid Carcinoma, Anaplastic; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Microsatellite instability-high cancer; Colorectal Neoplasms; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Gastrointestinal Neoplasms Details
Camrelizumab INCSHR-1210; HR-301210; SHR-1210; SHR01210 Approved Jiangsu Hengrui Medicine Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd AiRuiKa, 艾立妥, 艾瑞卡 Mainland China Hodgkin Disease Suzhou Suncadia Biopharmaceuticals Co Ltd 2019-05-29 Lung Neoplasms; Nasopharyngeal Carcinoma; Breast Neoplasms; Lymphoma, Extranodal NK-T-Cell; Cholangiocarcinoma; Sarcoma; Colorectal Neoplasms; Genital Neoplasms, Female; Urologic Neoplasms; Esophageal adenocarcinoma; Esophageal Squamous Cell Carcinoma; Lymphoma; Respiratory Tract Neoplasms; Carcinoma, Squamous Cell; Endometrial Neoplasms; Paranasal Sinus Neoplasms; Uterine Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Gastrointestinal Neoplasms; Neoplasm Metastasis; Esophageal Diseases; Neoplasms; Biliary Tract Neoplasms; Liver Neoplasms; Carcinoma, Bronchogenic; Ovarian Neoplasms; Hemorrhagic Fever, Ebola; Esophageal Neoplasms; Stomach Neoplasms; Bronchial Neoplasms; Thoracic Neoplasms; Carcinoma, Renal Cell; Rectal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Hodgkin Disease; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma; Hypopharyngeal Neoplasms; Carcinoma, Transitional Cell; Respiratory Tract Diseases; Lymphoma, Large B-Cel Details
Pembrolizumab SCH-900475; h409A11; MK-3475 Approved Merck & Co Inc 可瑞达, Keytruda United States Melanoma Merck Sharp & Dohme Corp 2014-09-04 Solid tumours; Biliary Tract Neoplasms; Lymphoma, B-Cell; HIV Infections; Hematologic Neoplasms; Liver Neoplasms; Ovarian Neoplasms; Head and Neck Neoplasms; Kidney Neoplasms; Ependymoma; Colorectal Neoplasms, Hereditary Nonpolyposis; Medulloblastoma; Bone metastases; Intestinal Neoplasms; Erythema; Ovarian germ cell tumor; Leiomyosarcoma; Lymphoma, T-Cell, Peripheral; Lymphoma, B-Cell, Marginal Zone; Neoplasm, Residual; Neoplasm Recurrence, Local; Thyroid Diseases; Anus Neoplasms; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Carcinoma, Renal Cell; Polycythemia Vera; Carcinoma; Carcinoma, Merkel Cell; Carcinoid Tumor; Rectal Neoplasms; Vaginal Diseases; Spinal Cord Neoplasms; Mismatch Repair Deficient Cancer; Vaginitis; Pheochromocytoma; Cystadenocarcinoma, Serous; Leukemia, Lymphoid; Genital Neoplasms, Male; Thoracic Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Transitional Cell; Hodgkin Disease; Salivary Gland Neoplasms; I Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
PD-1 Monoclonal Antibody(Sixth Affiliated Hospital Sun Yat-Sen University) Phase 2 Clinical Sixth Affiliated Hospital Sun Yat-Sen University Neoplasms; Colorectal Neoplasms Details
INCA-32459 INCA-32459 Phase 1 Clinical Incyte Corp, Merus Nv Neoplasms Details
Recombinant humanized anti-PD-1 monoclonal antibody (Shanghai CP Guojian) 609-A; SSGJ-609A; SSGJ-609-A Phase 2 Clinical Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Solid tumours; Sarcoma; Breast Neoplasms Details
Peramprizumab Phase 2 Clinical Sun Yat-Sen University Nasopharyngeal Carcinoma Details
IBI-321 IBI-321 Phase 1 Clinical Innovent Biologics(Suzhou) Co Ltd Solid tumours; Neoplasms Details
IAP-0971 IAP-0971 Phase 2 Clinical SunHo (China) BioPharmaceutical Co Ltd Solid tumours; Neoplasms; Urinary Bladder Neoplasms Details
EGFRvIII-directed CAR-T cell tharapy (Novartis/University of Pennsylvania) LXF-821 Phase 1 Clinical University Of Pennsylvania, Novartis Pharma Ag Glioblastoma Details
Izuralimab XmAb-23104; XmAb-104 Phase 2 Clinical Xencor Inc Sarcoma; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Endometrial Neoplasms; Colorectal Neoplasms; Breast Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms Details
TC-510 TC-510 Phase 2 Clinical Tcr2 Therapeutics Inc Ovarian Neoplasms; Solid tumours; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Mesothelioma; Cholangiocarcinoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma Details
ONO-4685 ONO-4685 Phase 1 Clinical Merus Nv Psoriasis; Lymphoma, T-Cell; Plaque psoriasis Details
Rosnilimab ANB-030 Phase 2 Clinical Anaptysbio Inc Alopecia Areata; Arthritis, Rheumatoid; Colitis, Ulcerative Details
CA-170 CA-170; AUPM-170 Phase 1 Clinical Aurigene Solid tumours Details
Anti-CTLA-4/PD-1 expressing EGFR-CAR-T Phase 2 Clinical Shanghai Cell Therapy Research Institute Solid tumours Details
Anti-PD1/anti-TIM3 bispecific antibody (L&L vision biopharmaceuticals) Bis-5 Phase 1 Clinical L&L Biopharma Co Ltd Neoplasms Details
TY-101 TY-101; TY101 Phase 2 Clinical Tayu Huaxia Biotech Medical Group Co Ltd Solid tumours; Lymphoma Details
Tobemstomig RO-7247669 Phase 2 Clinical F. Hoffmann-La Roche Ltd Solid tumours; Liver Neoplasms; Carcinoma; Carcinoma, Renal Cell; Neoplasms; Carcinoma, Transitional Cell; Breast Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details
Pradusinstobart LVGN-3616; SSI-361 Phase 2 Clinical Lyvgen Biopharma(HK)Ltd Head and Neck Neoplasms; Solid tumours; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Papillomavirus Infections; Uveal melanoma; Sarcoma; Carcinoma, Hepatocellular; Neoplasm Metastasis Details
BAT-3306 BAT3306; BAT-3306 Phase 1 Clinical Bio-Thera Solutions Ltd Details
Lomvastomig RG-7769; RO-7121661 Phase 2 Clinical F. Hoffmann-La Roche Ltd Solid tumours; Neoplasms; Small Cell Lung Carcinoma; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma Details
SSGJ-706 SSGJ-706 Phase 1 Clinical Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Solid tumours; Lymphoma Details
SSGJ-705 SSGJ-705 Phase 1 Clinical Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Solid tumours; Neoplasms Details
PD-1 Inhibitor Therapy(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University) Phase 3 Clinical Sun Yat-Sen Memorial Hospital Of Sun Yat-Sen University Rejection of liver transplantation; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Hepatocellular Details
RG-6279 RG-6279 Phase 1 Clinical F. Hoffmann-La Roche Ltd Solid tumours Details
JS-201 JS-201 Phase 1 Clinical Shanghai Junshi Biosciences Co Ltd Neoplasms Details
ASKG-915 ASKG-915 Phase 1 Clinical Askgene Pharma Solid tumours; Neoplasms Details
GME-751 GME751; GME-751 Phase 3 Clinical Sandoz Melanoma; Carcinoma, Non-Small-Cell Lung Details
LBL-015 LBL-015 Phase 2 Clinical Nanjing Leads Biolabs Co Ltd Solid tumours Details
Anti-CTLA-4 and PD-1 CAR-T cell therapy (Shanghai Cell Therapy Research Institute) Phase 2 Clinical Shanghai Cell Therapy Research Institute Neoplasms Details
Pimivalimab JTX-4014 Phase 2 Clinical Jounce Therapeutics Inc Neoplasms; Carcinoma, Non-Small-Cell Lung Details
HX-009 HX-009 Phase 2 Clinical Hanx Biopharmaceutical Co Ltd, Wuhan Hanxiong Biotechnology Co Ltd Solid tumours; Liver Neoplasms; Stomach Neoplasms; Lymphoma Details
RB-0004 RB-0004 Phase 1 Clinical Reyoung Pharmaceutical Co Ltd Solid tumours; Lymphoma Details
Zeluvalimab AMG-404 Phase 1 Clinical Amgen Inc Solid tumours; Small Cell Lung Carcinoma; Prostatic Neoplasms, Castration-Resistant; Precursor Cell Lymphoblastic Leukemia-Lymphoma Details
PF-07209960 PF-07209960 Phase 1 Clinical Pfizer Inc Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
EBV-specific TCR-T cell with anti-PD1 auto-secreted element Phase 2 Clinical Tcrcure Biopharma Ltd Squamous Cell Carcinoma of Head and Neck Details
MK-3475A MK-3475A Phase 3 Clinical Merck Sharp & Dohme Corp Solid tumours; Ovarian Neoplasms; Carcinoma, Renal Cell; Lung Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Melanoma Details
SPX-303 SPX-303 Phase 1 Clinical SparX Biopharmaceutical Corp Solid tumours Details
INCA33890 INCA33890; INCA-33890 Phase 1 Clinical Incyte Corp Solid tumours; Neoplasms; Neoplasm Metastasis Details
PD-1 knockout engineered T cells (Chengdu MedGenCell) Phase 2 Clinical West China Hospital Of Sichuan University, Chengdu Medgencell Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma Details
PD-1 Inhibitor Therapy(Beijing YouAn Hospital) Phase 2 Clinical Beijing Youan Hospbeijing Youan Hospital,Capital Medical Universityital,Capital Medical University, Beijing Gene Key Life Technology Co Ltd Carcinoma, Hepatocellular Details
CC-90006 C-90006; CC-90006 Phase 1 Clinical Anaptysbio Inc Autoimmune Diseases; Psoriasis Details
NWY-001(Biocytogen Pharmaceuticals) NWY001(Biocytogen Pharmaceuticals); YH008; YH-008; NWY-001(Biocytogen Pharmaceuticals) Phase 1 Clinical Eucure Pharmaceutical Technology (Beijing) Co Ltd, Biocytogen Pharmaceuticals (Beijing) Co Ltd Solid tumours; Hematologic Neoplasms; Neoplasms Details
PD-1 knockout engineered T cells (Anhui Kedgene Biotechnology) Phase 2 Clinical Anhui Korton Biological Technology Co Ltd, Hangzhou Cancer Hospital Esophageal Neoplasms; Carcinoma, Hepatocellular Details
Nofazinlimab CS-1003 Phase 3 Clinical Cstone Pharmaceuticals Solid tumours; Neoplasms; Lymphoma; Carcinoma, Hepatocellular Details
Taminadenant NIR-178; PBF-509 Phase 1 Clinical Palobiofarma Sl Solid tumours; Ovarian Neoplasms; Head and Neck Neoplasms; Carcinoma, Renal Cell; Carcinoma; Triple Negative Breast Neoplasms; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Colorectal Neoplasms; Parkinson Disease; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Melanoma Details
dPD-1 hCD19 CART cell therapy (Innovative Cellular Therapeutics) ICTCAR-014 Phase 2 Clinical Innovative Cellular Therapeutics Co Ltd Lymphoma, Non-Hodgkin Details
Multiple target antigen stimulating cell therapy (HengRui YuanZheng Biotechnology) Phase 2 Clinical Hengrui Yuanzheng (Shanghai) Biotechnology Co Ltd Solid tumours; Liver Neoplasms; Stomach Neoplasms; Neoplasms; Liver Diseases Details
PE0105 PE-0105 Phase 1 Clinical Shanghai Yunyi Health Technology Development Co Ltd Solid tumours; Neoplasms Details
PD-1 Inhibitor Therapy(Affiliated Hospital of Nantong University) Phase 2 Clinical Affiliated Hospital Of Nantong University Esophageal Squamous Cell Carcinoma Details
SI-B003 SI-B003 Phase 2 Clinical Sichuan Baili Pharmaceutical Co Ltd Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis; Melanoma Details
Pembrolizumab biosimilar (biocad) BCD-201 Phase 3 Clinical Biocad Solid tumours; Carcinoma, Non-Small-Cell Lung; Melanoma Details
PD-1 Inhibitor Therapy(Hunan Cancer Hospital) Hunan Cancer Hospital Details
PD-1 inhibitor therapy(Shanghai Chest Hospital) Phase 2 Clinical Shanghai Chest Hospital Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma Details
Spartalizumab PDR-001 Phase 3 Clinical Novartis Pharma Ag Esophageal Squamous Cell Carcinoma; Chordoma; Digestive System Neoplasms; Neuroendocrine Tumors; Breast Neoplasms; Sarcoma; Prostatic Neoplasms; Cholangiocarcinoma; Nasopharyngeal Carcinoma; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Primary Myelofibrosis; Bone Marrow Diseases; Esophageal adenocarcinoma; Endometrial Neoplasms; Carcinoma, Squamous Cell; Microsatellite instability-high cancer; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Sarcoma, Alveolar Soft Part; Leukemia, Myeloid, Acute; Thyroid Neoplasms; Metastatic breast cancer; Uterine Neoplasms; Lymphoma; Adenocarcinoma; Persistent Fetal Circulation Syndrome; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Lymphoma, Large B-Cell, Diffuse; Solid tumours; Ovarian Neoplasms; Liver Neoplasms; Leukemia, Myeloid; Leukemia; Kidney Neoplasms; Preleukemia; Hematologic Diseases; Carcinoma, Renal Cell; Carcinoma; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Anus Neoplasms; Triple Negati Details
Tebotelimab PD-1 X LAG-3; MGD-013 Phase 3 Clinical Macrogenics Inc Triple Negative Breast Neoplasms; Adenocarcinoma; Carcinoma, Hepatocellular; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis; Endometrial Neoplasms; Cholangiocarcinoma; Neoplasms; Solid tumours; Small Cell Lung Carcinoma; Esophageal Neoplasms; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Liver Neoplasms; Biliary Tract Neoplasms; Hematologic Neoplasms; Ovarian Neoplasms; Head and Neck Neoplasms Details
Ezabenlimab BI-754091 Phase 2 Clinical C.H. Boehringer Sohn Ag & Co. Kg Sarcoma; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Carcinoma, Neuroendocrine; Lung Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Colonic Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Liver Neoplasms; Biliary Tract Neoplasms; Solid tumours Details
SAR-445877 SAR-445877; SAR445877 Phase 2 Clinical Sanofi Solid tumours Details
Autologous PD-1 antibody expressing mesothelin-targeted CAR-Tcells therapy (Shanghai Cell Therapy Research Institute) Phase 2 Clinical Shanghai Cell Therapy Research Institute Solid tumours Details
Pembrolizumab/Vibostolimab MK-7684A Phase 3 Clinical Merck & Co Inc Urinary Bladder Neoplasms; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Gallbladder Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Cholangiocarcinoma; Ovarian Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Small Cell Lung Carcinoma; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Hematologic Neoplasms Details
Rilvegostomig AZD-2936 Phase 3 Clinical Astrazeneca Plc Biliary Tract Neoplasms; Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Bile Duct Neoplasms; Carcinoma, Non-Small-Cell Lung Details
BAT-1308 BAT-1308 Phase 3 Clinical Bio-Thera Solutions Ltd Solid tumours; Endometrial Neoplasms; Uterine Cervical Neoplasms Details
Vudalimab XmAb-20717; XmAb-717; XmAb 717 Phase 2 Clinical Xencor Inc Thymoma; Adenocarcinoma, Clear Cell; Cholangiocarcinoma; Nasopharyngeal Carcinoma; Breast Neoplasms; Vulvar Neoplasms; Prostatic Neoplasms; Astrocytoma; Colorectal Neoplasms; Endometrial Neoplasms; Microsatellite instability-high cancer; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Thyroid Neoplasms; Uterine Cervical Neoplasms; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Ovarian Neoplasms; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Carcinoma, Basal Cell; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Biliary Tract Neoplasms; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Hodgkin Disease; Colonic Neoplasms; Adenoma, Acidophil; Mesothelioma; Adnexal Diseases; Prostatic Neoplasms, Castration-Resistant Details
BCMA-PD1 CAR T cell therapy (General Hospital of the People's Liberation Army) Phase 2 Clinical People'S Liberation Army General Hospital Military Service Multiple Myeloma Details
BCD-217 BCD-217 Phase 3 Clinical Biocad Melanoma Details
CD19-PD1-CAR T cell therapy (Chinese PLA General Hospital) Phase 2 Clinical Pla General Hospital Lymphoma, B-Cell Details
Rulonilimab F-520 Phase 3 Clinical Shandong New Time Pharmaceutical Co Ltd Lymphoma, T-Cell, Peripheral; Solid tumours; Neoplasms; Carcinoma, Transitional Cell; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Central Nervous System Lymphoma; Uterine Cervical Neoplasms Details
89Zr-N-sucDf-pembrolizumab Phase 1 Clinical Merck & Co Inc, Umcg The University Medical Center Groningen Melanoma; Carcinoma, Non-Small-Cell Lung Details
CD-200-AR-L CD-200-AR-L; hP-1-A-8 Phase 1 Clinical University Of Minnesota Glioblastoma Details
Peresolimab LY-3462817 Phase 2 Clinical Eli Lilly And Company Arthritis, Rheumatoid; Autoimmune Diseases; Connective Tissue Diseases; Immune System Diseases; Joint Diseases; Psoriasis; Musculoskeletal Diseases; Rheumatic Diseases; Arthritis Details
Latikafusp AMG-256 Phase 1 Clinical Amgen Inc Solid tumours Details
Recombinant humanized anti-PD-1 monoclonal antibody (Anhui Anke Biotechnology) Phase 2 Clinical Anhui Anke Biotechnology (Group) Co Ltd Esophageal Neoplasms; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Neoplasms; Lymphoma; Lung Neoplasms Details
Budigalimab ABBV-181 Phase 3 Clinical Abbvie Inc HIV Infections; Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
Lipustobart LZM-009 Phase 2 Clinical Livzon(Group) Pharmaceutical Factory Solid tumours; Thymoma; Carcinoma, Non-Small-Cell Lung Details
ABBV-1882 ABBV-1882 Phase 1 Clinical Abbvie Inc HIV Infections Details
Pidilizumab MDV-9300; CT-011 Phase 2 Clinical Curetech Ltd Ovarian Neoplasms; Carcinoma, Renal Cell; Lymphoma, Large B-Cell, Diffuse; Pancreatic Neoplasms; Colonic Neoplasms; Multiple Myeloma; Prostatic Neoplasms; Breast Neoplasms; Sarcoma; Colorectal Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Hepatitis C, Chronic; Melanoma; Carcinoma, Hepatocellular Details
MAX-10181 MAX-10181; MAX-1 Phase 2 Clinical Maxinovel Pharmaceuticals Co Ltd Solid tumours; Neoplasms Details
Nivolumab biosimilar(Amgen) ABP-206 Phase 3 Clinical Amgen Inc Melanoma Details
MEDI-0680 AMP-514; MEDI-0680 Phase 2 Clinical Medimmune Lymphoma, B-Cell; Kidney Neoplasms; Carcinoma, Renal Cell; Neoplasms Details
Acrixolimab YBL-006; YBL 006 Phase 2 Clinical Y-biologics Inc Solid tumours Details
RO-7284755 RO-7284755 Phase 1 Clinical F. Hoffmann-La Roche Ag Solid tumours; Neoplasms Details
MiHA-loaded PD-L silenced DC vaccination (Radboud University) Phase 2 Clinical Radboud University Nijmegen Hematologic Neoplasms; Colorectal Neoplasms Details
Sym-021 Sym-021 Phase 1 Clinical Symphogen A/S Solid tumours; Lymphoma; Neoplasm Metastasis Details
SHR-1901 SHR-1901 Phase 1 Clinical Suzhou Suncadia Biopharmaceuticals Co Ltd Neoplasms Details
TQB-2868 TQB-2868 Phase 2 Clinical Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular Details
Mavezelimab/Pembrolizumab MK-4280A; MK-4820A Phase 3 Clinical Msd Ireland (Carlow) Merck Sharp & Dohme Corp, MSD R&D(China)Co Ltd Solid tumours; Carcinoma, Renal Cell; Hodgkin Disease; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Colorectal Neoplasms; Carcinoma, Squamous Cell; Endometrial Neoplasms Details
BA1104 LY-01015; BA-1104 Phase 3 Clinical Luye Pharma Group Ltd Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Mesothelioma; Urinary Bladder Neoplasms; Glioma; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma Details
Genolimzumab GB-226; APL-501; APL501; CBT-501; GB226 Phase 2 Clinical Cbt, Genor Biopharma Co Ltd, Apollomics Inc Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Neoplasms, Unknown Primary; Lymphoma, Non-Hodgkin; Lymphoma; Sarcoma, Alveolar Soft Part; Thymoma; Lymphoma, T-Cell, Peripheral; Thymus Neoplasms; Microsatellite Instability; Hodgkin Disease; Carcinoma, Renal Cell; Mismatch Repair Deficient Cancer; Lymphoma, B-Cell; Solid tumours Details
Lorigerlimab MGD-019; AEX1344 Phase 2 Clinical Macrogenics Inc Solid tumours; Liver Neoplasms; Skin Melanoma; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Neoplasms; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Colorectal Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Pancreatic Ductal; Uterine Cervical Neoplasms; Neoplasm Metastasis; Melanoma; Carcinoma, Non-Small-Cell Lung Details
Sym-024 Sym-024; S-95024 Phase 1 Clinical Symphogen A/S Solid tumours; Neoplasm Metastasis Details
Recombinant human anti-PD-1 monoclonal antibody(Hec Biological) Phase 1 Clinical Dongguan City Hec Biological Medicine Res And Development Co Ltd Stomach Neoplasms; Esophageal adenocarcinoma Details
T3011 MVR-T3011; T3011; MVR-T3011 IT; MVR-T3011 IV Phase 2 Clinical Immvira Co Ltd Sarcoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Melanoma; Carcinoma, Squamous Cell; Lymphoma; Lung Neoplasms; Endometrial Neoplasms; Colorectal Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Mesothelioma; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Solid tumours; Head and Neck Neoplasms; Liver Neoplasms Details
GX-P1 GX-P1 Phase 1 Clinical Genexine Inc Autoimmune Diseases Details
EMB-02 EMB-02 Phase 2 Clinical Shanghai Epimab Biotherapeutics, Inc Solid tumours Details
PD-1 knockout EBV-CTL (Nanjing Medical University) Phase 2 Clinical Nanjing Medical University Stomach Neoplasms; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Neoplasms; Lymphoma Details
Recombinant human PD-1 antibody herpes simplex virus Phase 1 Clinical Yangsheng Tang Co Ltd, Xiamen University Liver Neoplasms; Solid tumours; Head and Neck Neoplasms; Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Central Nervous System Neoplasms; Colorectal Neoplasms; Brain metastases; Lung Neoplasms; Melanoma; Uterine Cervical Neoplasms Details
IMU-201 IMU-201 Phase 1 Clinical Imugene Ltd Adenocarcinoma of Lung; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
HerinCAR-PD1 Phase 2 Clinical Ningbo Cancer Hospital Solid tumours Details
CD19 PD-1/CD28 CAR-T Cell Therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine) Phase 1 Clinical Second Affiliated Hospital Of Zhejiang University School Of Medicine Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Primary mediastinal B cell lymphoma Details
PH-762 PH-762; PH762-ACT; RXI 762-ACT Phase 1 Clinical Phio Pharmaceuticals Corp Skin Melanoma; Squamous Cell Carcinoma of Head and Neck; Skin Neoplasms; Breast Neoplasms; Genital Neoplasms, Female; Colorectal Neoplasms; Carcinoma, Squamous Cell; Urogenital Neoplasms; Lung Neoplasms; Melanoma Details
AK-129 AK-129 Phase 1 Clinical Zhongshan Akeso Biopharma Co Ltd Neoplasms Details
Fidasimtamab IBI-315 Phase 1 Clinical Hanmi Pharmaceutical Co Ltd, Innovent Biologics(Suzhou) Co Ltd Solid tumours; Neoplasms Details
STW204 STW-204; AI025; AI-025 Phase 1 Clinical Suzhou Stainwei Biotech Inc Solid tumours; Neoplasms Details
ZG-005 ZG-005 Phase 2 Clinical Suzhou Zelgen Biopharmaceuticals Co Ltd Solid tumours; Carcinoma, Neuroendocrine; Uterine Cervical Neoplasms Details
STW204/Gotistobart AI-061 Phase 1 Clinical Oncoc4 Inc Bile Duct Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms; Melanoma; Carcinoma, Hepatocellular; Endometrial Neoplasms; Fallopian Tube Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell; Peritoneal Neoplasms; Urinary Bladder Neoplasms; Digestive System Neoplasms; Stomach Neoplasms; Anus Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Cystadenocarcinoma, Serous Details
KY-0118 KY-0118; KY0118 Phase 1 Clinical Novatim Immune Therapeutics (Zhejiang) Co Ltd Solid tumours; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung Details
JNJ-67484703 JNJ-67484703; JNJ-4703 Phase 1 Clinical Janssen Research & Development Llc Arthritis, Rheumatoid Details
INSIX RA (Indus Biotech) Clinical Indus Biotech Pvt Ltd Arthritis, Rheumatoid; Inflammation Details
VT1093 VT1093; VT-1093 Phase 1 Clinical Beijing Weiyuan Likang Biotechnology Co Ltd Solid tumours Details
CMAB-819 CMAB8-19 Phase 1 Clinical Sinomab Bioscience Ltd Squamous Cell Carcinoma of Head and Neck; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
BCD-263 BCD-263 Phase 1 Clinical Biocad Melanoma Details
CDX-585 CDX-585 Phase 1 Clinical Boaoxin Biotechnology(Nanjing) Co Ltd, Celldex Therapeutics Liver Neoplasms; Ovarian Neoplasms; Head and Neck Neoplasms; Solid tumours; Carcinoma, Renal Cell; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Recombinant humanized anti-PD-1 monoclonal antibody (Shanxi Wichida Bright Pharmaceutical) Phase 1 Clinical Shanxi Weiqidaguangming Pharmaceutical Co Ltd Solid tumours Details
MW-11 MW-11; 9MW1111; 9-MW1111; 9MW-1111; 9-MW-1111 Phase 1 Clinical Mabwell (Shanghai) Bioscience Co Ltd Solid tumours; Breast Neoplasms Details
Reozalimab IBI-318; LY-3434172; LY3434172 Phase 1 Clinical Innovent Biologics(Suzhou) Co Ltd, Eli Lilly And Company Neoplasms; Small Cell Lung Carcinoma; Lymphoma, Extranodal NK-T-Cell; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular Details
GNR-051 GNR-051 Phase 1 Clinical Generium Pharmaceuticals Carcinoma, Renal Cell; Melanoma; Carcinoma, Non-Small-Cell Lung Details
SOT-201 SOT-201 Phase 1 Clinical Sotio Solid tumours; Neoplasms; Neoplasm Metastasis Details
AZD-7789 AZD-7789 Phase 2 Clinical AstraZeneca Ag Esophageal Neoplasms; Stomach Neoplasms; Hodgkin Disease; Digestive System Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms Details
Pegylated recombinant human granulocyte colony stimulating factor(Sun Yat-sen University) Phase 1 Clinical Sun Yat-Sen University Hematologic Neoplasms; Nasopharyngeal Carcinoma Details
IBI-319 IBI-319 Phase 1 Clinical Innovent Biologics(Suzhou) Co Ltd Neoplasms Details
Sasanlimab PF-6801591; PF-06801591; RN-888 Phase 3 Clinical Pfizer Pharmaceuticals Ltd (China), Pfizer Inc Urinary Bladder Neoplasms; Fructose Intolerance; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Melanoma; Urogenital Neoplasms; Endometrial Neoplasms; Carcinoma, Squamous Cell; Bile Duct Neoplasms; Colorectal Neoplasms; Urologic Neoplasms; Prostatic Neoplasms; Sarcoma; Urologic Diseases; Digestive System Neoplasms; Kidney Neoplasms; Kidney Diseases; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Neoplasms; Neoplasms, Glandular and Epithelial; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Carcinoma; Ovarian Neoplasms; Solid tumours; Head and Neck Neoplasms; Liver Neoplasms Details
Treprilimab Clinical Sun Yat-Sen University Oropharyngeal Neoplasms Details
Cetrelimab JNJ-63723283; JNJ-3283 Phase 3 Clinical Johnson & Johnson Hepatitis B, Chronic; Neoplasms; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Melanoma; Carcinoma, Non-Small-Cell Lung Details
Rituximab/Paclitaxel AR-160 Phase 1 Clinical Mayo Clinic Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell Details
Mableukin 2PD1(Anwita Biosciences) AWT020; AWT-020 Phase 1 Clinical Anwita Biosciences Inc Neoplasms; Autoimmune Diseases of the Nervous System Details
Pembrolizumab/Quavonlimab MK-1308A Phase 3 Clinical Merck Sharp & Dohme Corp, Msd Ireland (Carlow), MSD R&D(China)Co Ltd Solid tumours; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Colorectal Neoplasms; Carcinoma, Hepatocellular; Melanoma Details
JS-207 JS-207 Phase 1 Clinical Shanghai Junshi Biological Engineering Co Ltd Neoplasms Details
Anti-PD-1 Antibody(Fujian Cancer Hospital) Phase 2 Clinical Fujian Cancer Hospital Carcinoma, Hepatocellular Details
64Cu-DOTA-nivolumab (Bristol-Myers Squibb/Ono Pharmaceutical) Clinical Ono Pharmaceutical Co Ltd, Bristol-Myers Squibb Company Melanoma; Carcinoma, Non-Small-Cell Lung Details
IBI-363 IBI-363 Phase 2 Clinical Innovent Biologics(Suzhou) Co Ltd Solid tumours; Neoplasms; Lymphoma; Melanoma Details
αPD1-MSLN-CAR T cell therapy (Shanghai Cell Therapy Group Co.,Ltd) BZDS1901; BZDS-1901; BZD1901 Phase 1 Clinical Shanghai Cell Therapy Group Co Ltd Ovarian Neoplasms; Solid tumours; Mesothelioma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
AK-131 AK-131 Phase 1 Clinical Zhongshan Akeso Biopharma Co Ltd Solid tumours; Neoplasms Details
Volrustomig MEDI-5752; MEDI5752 Phase 3 Clinical Medimmune Llc Biliary Tract Neoplasms; Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Mesothelioma; Sarcoma; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Nachricht schicken